Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71.3 CAD | -1.34% | -6.07% | +22.59% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.85% | 289B | |
+10.56% | 150B | |
+41.54% | 119B | |
+22.45% | 82.56B | |
+9.47% | 76.16B | |
+19.08% | 62.56B | |
+10.50% | 58.49B | |
+4.61% | 46.31B | |
-5.18% | 36.05B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv : Morgan Stanley Adjusts Price Target on Ovintiv to $42 From $35, Maintains Overweight Rating